PAS
MRVI icon

Point72 Asia (Singapore)’s Maravai LifeSciences MRVI Stock Holding History

Point72 Asia (Singapore)’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$24.5K Buy
+8,522
New +$21.8K ﹤0.01% 674
2024
Q3 		– Sell
-4,449
Closed -$31.9K – 1190
2024
Q2 		$31.9K Buy
+4,449
New +$38.4K 0.01% 758
2024
Q1 		– Sell
-8,000
Closed -$52.4K – 1171
2023
Q4 		$52.4K Buy
+8,000
New +$51.7K 0.01% 300

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Point72 Asia (Singapore)'s MRVI Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Maravai LifeSciences (MRVI) in Q3 2025: 8,522 shares worth $24.5K. The stake represents ﹤0.01% of the portfolio and ranks #674 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in MRVI as recently as Q2 2024.

Point72 Asia (Singapore) first reported a position in MRVI in Q4 2023 and has held it in 3 quarters since. The position peaked at $52.4K in Q4 2023. 160 funds tracked by Wall St. Rank hold MRVI as of Q3 2025.

  • Point72 Asia (Singapore) held 8,522 shares of Maravai LifeSciences worth $24.5K as of Q3 2025.
  • Maravai LifeSciences was a new Point72 Asia (Singapore) position in Q3 2025.
  • Maravai LifeSciences made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #674 holding.
  • Point72 Asia (Singapore) first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s Maravai LifeSciences position peaked at $52.4K in Q4 2023.
  • 160 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.